Tag: Progression-Free Survival

A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...

A retrospective study of 203 patients found that post-radiotherapy levels of the prognostic nutritional index and lactate dehydrogenase stratified extensive-stage ...

A phase II trial found that nanoparticle polymeric micellar paclitaxel combined with carboplatin and sintilimab produced an objective response rate ...

A new network meta-analysis of five trials involving 2,452 patients finds that triple therapy combining immunotherapy, antiangiogenic antibodies, and chemotherapy ...

A retrospective study of 154 glioblastoma patients found that 5-ALA and sodium fluorescein produced nearly identical resection volumes, yet 5-ALA ...

A meta-analysis of 64 studies shows that elevated or rising circulating tumour DNA levels in the blood strongly predict poorer ...

A nationwide cohort of 410 patients shows zanubrutinib delivers high progression-free survival in CLL/SLL, with dose reductions and switches between ...

A large single-center analysis finds that metastatic metaplastic triple-negative breast cancer responds less well to sacituzumab govitecan than typical triple-negative ...

A phase 1b/2 trial found that the oral CBP–β-catenin inhibitor E7386 combined with lenvatinib produced durable responses in advanced endometrial ...

A propensity score-matched cohort study finds that meningiomas arising after cranial radiotherapy relapse significantly earlier than sporadic tumors, even after ...